The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma.
 
Jason A. Konner
Consulting or Advisory Role - Clovis Oncology; Genentech/Roche
Research Funding - AstraZeneca/MedImmune; Genentech/Roche; TapImmune Inc.
 
Nicole N Boucicaut
No Relationships to Disclose
 
Roisin Eilish O'Cearbhaill
Consulting or Advisory Role - Clovis Oncology
Research Funding - Janssen Oncology (Inst); Juno Therapeutics (Inst); Ludwig Institute for Cancer Research (Inst); OncoMed (Inst); Sellas Life Sciences (Inst)
 
Dmitriy Zamarin
Employment - Acorda Therapeutics (I)
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)
Travel, Accommodations, Expenses - Targovax
 
Vicky Makker
No Relationships to Disclose
 
Paul Sabbatini
Research Funding - Bristol-Myers Squibb (Inst); Ludwig Institute for Cancer Research (Inst)
 
William P. Tew
No Relationships to Disclose
 
Karen Anne Cadoo
Research Funding - AstraZeneca (Inst)
 
Rachel N. Grisham
No Relationships to Disclose
 
Carol Aghajanian
Consulting or Advisory Role - Bayer; Cerulean Pharma; Cerulean Pharma; Oxigene; VentiRx